Management of acute attacks of hereditary angioedema: role of ecallantide

References

• BerryAFirsztRSuccessful treatment of idiopathic angioedema with ecallantideJ Allergy Clin Immunol201313297298
   Web of Science ®Google Scholar
• ZurawBLHereditary angioedemaN Engl J Med2008359101027103618768946
   PubMed Web of Science ®Google Scholar
• CicardiMAgostoniAHereditary angioedemaN Engl J Med199633425166616678628365
   PubMed Web of Science ®Google Scholar
• BygumAHereditary angio-oedema in Denmark: a nationwide surveyBr J Dermatol200916151153115819709101
   PubMed Web of Science ®Google Scholar
• RocheOBlanchACaballeroTSastreNCallejoDLopez-TrascasaMHereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainAnn Allergy Asthma Immunol200594449850315875532
   PubMed Web of Science ®Google Scholar
• PsarrosFKoutsostathisNFarmakiESpeletasMGGermeniaAEHereditary angioedema in Greece: the first results of the Greek hereditary angioedema registryInt Arch Allergy Immunol2014164432633225277223
   PubMed Web of Science ®Google Scholar
• Aygören-PürsünEBygumABeusterienKSocioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in EuropeOrphanet J Rare Dis201499924996814
   PubMed Web of Science ®Google Scholar
• MacginnitieAJDavis-LortonMStolzLETachdjianRUse of ecallantide in pediatric hereditary angioedemaPediatrics20131322e490e49723878046
   PubMed Web of Science ®Google Scholar
• BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs and courseAm J Med2006119326727416490473
   PubMed Web of Science ®Google Scholar
• JollesSWilliamsPCarneEA UK national audit of hereditary and acquired angioedemaClin Exp Immunol20131751596723786259
   PubMed Web of Science ®Google Scholar
• BorkKHardtJSchicketanzKResselNClinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiencyArch Intern Med2003163101229123512767961
   PubMedGoogle Scholar
• SardanaNCraigTAdvances in management and treatment of hereditary angioedemaPediatrics201112861173118022065270
   PubMed Web of Science ®Google Scholar
• ZurawBLBorkKBinkleyKEHereditary angioedema with normal C1 inhibitor function: consensus of an international expert panelAllergy Asthma Proc201233Suppl 1S14523394603
   PubMed Web of Science ®Google Scholar
• CraigTAygören-PürsünEBorkKWAO guideline for the management of hereditary angioedemaWorld Allergy Organ J2012518219923282420
   PubMedGoogle Scholar
• DewaldGBorkKMissense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitorBiochem Biophys Res Commun200634341286128916638441
   PubMed Web of Science ®Google Scholar
• BasMAdamsVSuvoravaTNiehuesTHoffmannTKKojdaGNonallergic angioedema: role of bradykininEur J Allergy Clin Immunol2007628842856
   Google Scholar
• GompelsMMLockRJMorganJEOsborneJBrownAVirgoPFA multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiencyJ Clin Pathol200255214511865013
   PubMed Web of Science ®Google Scholar
• CicardiMJohstonDTHereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the HematologistActa Haematol2012127420822022456031
   PubMed Web of Science ®Google Scholar
• KastinAJHandbook of Biologically Active Peptides2nd edMassachusettsAcademic Press2013
   Google Scholar
• BouilletLMannicTArboleasMHereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formationJ Allergy Clin Immunol2011128123223421439626
   PubMed Web of Science ®Google Scholar
• FrankMMUpdate on preventative therapy (prophylaxis) for hereditary angioedemaImmunol Allergy Clin North Am201333449550324176214
   PubMed Web of Science ®Google Scholar
• ZurawBYasothanUKirkpatrickPEcallantideNat Rev Drug Discov20109318919020190785
   PubMed Web of Science ®Google Scholar
• FarkasHVargaLEcallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyClin Cosmet Investig Dermatol201146168
   PubMedGoogle Scholar
• Garnock-JonesKPEcallantide in acute hereditary angioedemaDrugs201070111423143120614949
   PubMed Web of Science ®Google Scholar
• MartelloJLWoytowishMRChambersHEcallantide for treatment of acute attacks of hereditary angioedemaAm J Health Syst Pharm201269865165722472866
   PubMed Web of Science ®Google Scholar
• USFDACenter for Drug Evaluation and Research Application 125277: Ecallantide Summary Review of Regulatory Action [online]2009 Available from: http://www.accessdata.fda.gov.ezproxy.lib.utah.edu/drugsatfda_docs/nda/2009/125277s000SumR.pdfAccessed October 16, 2014
   Google Scholar
• LevyRJLumryWRMcNeilDLEDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaAnn Allergy Asthma Immunol2010104652352920568386
   PubMed Web of Science ®Google Scholar
• StolzLEShefferALProspective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedemaExpert Rev Clin Immunol201281253222149337
   PubMed Web of Science ®Google Scholar
• ShefferALMacGinnitieAJCampionMCStolzLEPullmanWEOutcomes after ecallantide treatment of laryngeal hereditary angioedema attacksAnn Allergy Asthma Immunol2013110318418823548529
   PubMed Web of Science ®Google Scholar
• BernsteinJASheaEPKoesterJIarrobinoRPullmanWEAssessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedemaEur J Allergy Clin Immunol201267911731180
   Google Scholar
• LiHHCampionMCraigTJAnalysis of hereditary angioedema attacks requiring a second dose of ecallantideAnn Allergy Asthma Immunol2013110316817223548526
   PubMed Web of Science ®Google Scholar
• DyTBRasheedMParikhPBernsteinBResolution of an acute attack of idiopathic angioedema with ecallantideAm Allergy Asthma Immunol20131113224226
   Web of Science ®Google Scholar
• BaramMKommuriASellersSACohnJRACE inhibitor-induced angioedemaJ Allergy Clin Immunol201315442445
   Web of Science ®Google Scholar
• PareGKuboMByrdJBGenetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedemaPharmacogenet Genomics201323947047823838604
   PubMed Web of Science ®Google Scholar
• CohnJRMcDanielCRichardsNAuCBaramMPrompt reversal of airway obstruction secondary to angiotensin converting enzyme inhibitor (ACEI) induced angioedema by ecallantide: a case reportJ Allergy Clin Immunol2012129Suppl 2AB220
   Web of Science ®Google Scholar
• LewisLGraffeoCCrosleyPEcallantide for the acute treatment of angiotensin converting enzyme inhibitor-induced angioedema: a multicenter randomized controlled trialAnn Emerg Med201362Suppl 2S132
   Google Scholar
• CicardiMZanichelliAAcquired angioedemaAllergy Asthma Clin Immunol2010611420667117
   PubMedGoogle Scholar
• Kalbitor® (Ecallantide)The Safety and Efficacy of Ecallantide in Patients with Acquired AngioedemaCambridge, MADyax Corp2014
   Google Scholar
• PatelNSFungSMZanichelliACicardiMCohnJREcallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiencyAllergy Asthma Proc2013341727723406939
   PubMed Web of Science ®Google Scholar
• LevyRMcNeilDLiHResults of a phase 3 double-blind, placebo-controlled trial, EDEMA3: a stubby of subcutaneous DX-88 (ecallantide) in patients with hereditary angioedema [abstract no 15]J Allergy Clin Immunol2008121Suppl 2AA6
   Google Scholar
• KALBITOR® (Ecallantide)Injection, for Subcutaneous Use [Prescribing Information] [online]Cambridge, MADyax Corp2014 Available from: http://www.kalbitor.com/hcp/rems/pdf/KalbitorFullPrescribing-Information.pdfAccessed October 18, 2014
   Google Scholar
• CraigTJLiHHRiedlMCharacterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacksJ Allergy Clin Immunol Pract20153220621225609335
   PubMed Web of Science ®Google Scholar
• KuhlenJGuyerAMorphewTTachdjianRBanerjiAAssessment of home infusion program for treating nonlaryngeal hereditary angioedema attacksAnn Allergy Asthma Immunol2014112547147224630437
   PubMed Web of Science ®Google Scholar
• WilsonDABorkKSheaEPRentzAMBlausteinMBPullmanWEEconomic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol20101044314e320e20408341
   PubMed Web of Science ®Google Scholar
• BurkeSPetrovAJohnsonJMacGinnitieASuccessful use of ecallantide to treat a hereditary angioedema attack after failure of C1 inhibitor prophylaxisAnn Allergy Asthma Immunol2011107218118221802029
   PubMed Web of Science ®Google Scholar
• ThomasMShahSNew treatment options for acute edema attacks caused by hereditary angioedemaAm J Health Syst Pharm201168222129213822058099
   PubMed Web of Science ®Google Scholar